No Data Yet
Organigram, Canada's top cannabis company by market share, appointed former British American Tobacco executive James Yamanaka as its new CEO, effective January 15, 2026, to lead its global expansion efforts.
OrganiGram (OGI) reported a -1,900.00% earnings surprise for the quarter ending September 2025, despite a +7.10% revenue surprise.
Organigram Global reported a CAD 24.76 million net loss for fiscal 2025 while issuing ambitious guidance for net revenue to exceed CAD 300 million in fiscal 2026.